Sunday, 23 August 2026European Markets
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com

METABOLIC EXPLORER Stock Is 10% Up So Far Today

Loading stream...

(vianews) - shares of metabolic explorer (cac 40: metex.pa) jumped by a staggering 10.58% to €1.11 at 14:06 est on monday, after two successive sessions in a row of losses. cac 40 is jumping 0.7% to €7,263.33, following the last session's downward trend. this seems, at the moment, a somewhat positive trend exchanging session today.

metabolic explorer's last close was €1.00, 76.91% below its 52-week high of €4.34.

about metabolic explorer

metabolic explorer s.a., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. the company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and l-valine. its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. the company was incorporated in 1999 and is based in saint-beauzire, france.

earnings per share

as for profitability, metabolic explorer has a trailing twelve months eps of €-1.17.

revenue growth

year-on-year quarterly revenue growth declined by 26.9%, now sitting on 228.15m for the twelve trailing months.

moving average

metabolic explorer's value is above its 50-day moving average of €1.02 and way under its 200-day moving average of €1.40.

yearly top and bottom value

metabolic explorer's stock is valued at €1.11 at 14:06 est, way under its 52-week high of €4.34 and way higher than its 52-week low of €0.88.

more news about metabolic explorer (metex.pa).